Soligenix Initiates Radiation Enteritis Prevention Moves | Radiology
Links shared publicly online about this topic.
- 1,509total visits
Soligenix Initiates Radiation Enteritis Prevention Moves | Radiology
DOR BioPharma, Inc. announced that it has initiated a Phase 1/2 clinical trial evaluating SGX201, a time-release formulation of oral beclomethasone 17,21-dipropionate (oral BDP)
View full resource at medicexchange.com
Tags: Clinical Trial, Radiology, News, Radiation
Most Recently Shared on December 23, 2009 at 6:00 pm By:
Latest News Soligenix Initiates Radiation Enteritis Prevention Moves: Soligenix, Inc. formerly kn... http://bit.ly/7s5Xxq MedicExchange.com
Advertisement
